Mon, September 23, 2024
Fri, September 20, 2024
Thu, September 19, 2024
Wed, September 18, 2024
Tue, September 17, 2024
Mon, September 16, 2024

Adam Maeder Initiated (ABT) at Buy and Held Target at $131 on, Sep 19th, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. buy-and-held-target-at-131-on-sep-19th-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Adam Maeder of Piper Sandler, Initiated "Abbott Laboratories" (ABT) at Buy and Held Target at $131 on, Sep 19th, 2024.

Adam has made no other calls on ABT in the last 4 months.



There are 6 other peers that have a rating on ABT. Out of the 6 peers that are also analyzing ABT, 0 agree with Adam's Rating of Hold.



These are the ratings of the 6 analyists that currently disagree with Adam


  • Raj Denhoy of "Jefferies" Maintained at Strong Buy with Increased Target to $120 on, Tuesday, August 27th, 2024
  • Joanna Wiensch of "Citigroup" Maintained at Strong Buy with Increased Target to $127 on, Thursday, August 22nd, 2024
  • Matt Miksic of "Barclays" Maintained at Buy with Increased Target to $143 on, Monday, July 29th, 2024
  • Vijay Kumar of "Evercore ISI Group" Maintained at Buy with Decreased Target to $120 on, Tuesday, July 2nd, 2024
  • Shagun Singh of "RBC Capital" Reiterated at Buy and Held Target at $125 on, Tuesday, June 4th, 2024
  • David Roman of "Goldman Sachs" Initiated at Strong Buy and Held Target at $121 on, Thursday, May 30th, 2024

Publication Contributing Sources